Literature DB >> 12037066

Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent.

Craig A Jackson1, Steven D Lovrich, William A Agger, Steven M Callister.   

Abstract

Previous studies from the late 1980s defined the risk of human Lyme disease by determining the prevalence of Borrelia burgdorferi infection in Ixodes scapularis ticks and Peromyscus sp. mice captured from areas around La Crosse, Wis. High percentages of B. burgdorferi-infected I. scapularis ticks and P. leucopus mice were common in areas located north of Interstate 90 but were not detected in areas south of this major east-west thoroughfare. In this study, we reevaluated the extent of B. burgdorferi infection. High percentages of mice captured from sites north of the interstate were still infected with B. burgdorferi. In addition, B. burgdorferi was recovered from 12 (67%) of 18 mice captured from a site well south of the highway. However, none of 104 mice or 713 I. scapularis ticks captured from the study sites were infected with Ehrlichia spp. The results confirmed the continued high risk for humans to contract infection with B. burgdorferi and the significant southward expansion of the area in which Lyme disease is endemic. In contrast, the risk of acquiring human granulocytic ehrlichiosis remains minimal despite the abundance of appropriate vector ticks and reservoir rodents.

Entities:  

Mesh:

Year:  2002        PMID: 12037066      PMCID: PMC130725          DOI: 10.1128/JCM.40.6.2070-2073.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.

Authors:  S R Telford; J E Dawson; P Katavolos; C K Warner; C P Kolbert; D H Persing
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Concentration of dilute protein solutions prior to sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  J Ziegler; T Vogt; O Miersch; D Strack
Journal:  Anal Biochem       Date:  1997-08-01       Impact factor: 3.365

3.  Ixodes scapularis (Acari:Ixodidae): status and changes in prevalence and distribution in Wisconsin between 1981 and 1994 measured by deer surveillance.

Authors:  M Riehle; S M Paskewitz
Journal:  J Med Entomol       Date:  1996-11       Impact factor: 2.278

Review 4.  Is human granulocytic ehrlichiosis a new Lyme disease? Review and comparison of clinical, laboratory, epidemiological, and some biological features.

Authors:  J S Dumler
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

5.  Prevalence of granulocytic Ehrlichia infection among white-tailed deer in Wisconsin.

Authors:  E A Belongia; K D Reed; P D Mitchell; C P Kolbert; D H Persing; J S Gill; J J Kazmierczak
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

6.  Lyme disease: clinical features, classification, and epidemiology in the upper midwest.

Authors:  W Agger; K L Case; G L Bryant; S M Callister
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

7.  Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi.

Authors:  S M Callister; K L Case; W A Agger; R F Schell; R C Johnson; J L Ellingson
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

8.  Recovery of Borrelia burgdorferi by filtration.

Authors:  D A Jobe; S M Callister; R F Schell
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

9.  Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

Authors:  J S Bakken; J S Dumler; S M Chen; M R Eckman; L L Van Etta; D H Walker
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

10.  Ixodes dammini as a potential vector of human granulocytic ehrlichiosis.

Authors:  P Pancholi; C P Kolbert; P D Mitchell; K D Reed; J S Dumler; J S Bakken; S R Telford; D H Persing
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

View more
  11 in total

1.  Vaccination with the ospA- and ospB-Negative Borrelia burgdorferi Strain 50772 Provides Significant Protection against Canine Lyme Disease.

Authors:  Rhonda L LaFleur; Steven M Callister; Jennifer C Dant; Terri L Wasmoen; Dean A Jobe; Steven D Lovrich
Journal:  Clin Vaccine Immunol       Date:  2015-05-13

2.  Expansion of the Midwestern focus for human granulocytic anaplasmosis into the region surrounding La Crosse, Wisconsin.

Authors:  Steven D Lovrich; Dean A Jobe; Todd J Kowalski; Seema M Policepatil; Steven M Callister
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

3.  One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin.

Authors:  Rhonda L LaFleur; Steven M Callister; Jennifer C Dant; Dean A Jobe; Steven D Lovrich; Thomas F Warner; Terri L Wasmoen; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2010-03-17

4.  Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease.

Authors:  Dean A Jobe; Todd J Kowalski; Marissa Bloemke; S D Lovrich; Steven M Callister
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

5.  Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.

Authors:  Rhonda L LaFleur; Jennifer C Dant; Terri L Wasmoen; Steven M Callister; Dean A Jobe; Steven D Lovrich; Thomas F Warner; O Abdelmagid; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

Review 6.  A review of studies on the transmission of Anaplasma phagocytophilum from sheep: implications for the force of infection in endemic cycles.

Authors:  N H Ogden; A N J Casey; N P French; Z Woldehiwet
Journal:  Exp Appl Acarol       Date:  2002       Impact factor: 2.132

7.  Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.

Authors:  Dean A Jobe; Steven D Lovrich; Krista E Asp; Michelle A Mathiason; Stephanie E Albrecht; Ronald F Schell; Steven M Callister
Journal:  Clin Vaccine Immunol       Date:  2008-04-16

8.  Detection of IFN-γ Secretion by T Cells Collected Before and After Successful Treatment of Early Lyme Disease.

Authors:  Steven M Callister; Dean A Jobe; Aleksandra Stuparic-Stancic; Misato Miyamasu; Jeff Boyle; Raymond J Dattwyler; Paul M Arnaboldi
Journal:  Clin Infect Dis       Date:  2016-03-01       Impact factor: 9.079

9.  Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease.

Authors:  Steven D Lovrich; Rhonda L La Fleur; Dean A Jobe; Jennifer C Johnson; Krista E Asp; Ronald F Schell; Steven M Callister
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

10.  Borrelia burgdorferi in Ixodes scapularis ticks, Chicago area.

Authors:  Dean A Jobe; Steven D Lovrich; Jeffrey A Nelson; Tom C Velat; Chris Anchor; Tad Koeune; Stephen A Martin
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.